Global Ursodeoxycholic Acid API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Ursodeoxycholic Acid API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear.

Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.

In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid API. In addition, the CAS number is 128-13-2.

According to our (Global Info Research) latest study, the global Ursodeoxycholic Acid API market size was valued at US$ 523 million in 2023 and is forecast to a readjusted size of USD 983 million by 2030 with a CAGR of 9.5% during review period.

Global key players of Ursodeoxycholic Acid API include ICE, Daewoong Chemical, PharmaZell GmbH and Zhongshan Bailing, etc. The top four players hold a share about 60%. APAC is the largest market, has a share about 50%. In terms of product type, Synthetic UDCA is the largest segment, occupied for a share of about 98%, and in terms of application, Pharmacy has a share about 90 percent.

This report is a detailed and comprehensive analysis for global Ursodeoxycholic Acid API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Ursodeoxycholic Acid API market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030

Global Ursodeoxycholic Acid API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030

Global Ursodeoxycholic Acid API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2019-2030

Global Ursodeoxycholic Acid API market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Ursodeoxycholic Acid API

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Ursodeoxycholic Acid API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Zhongshan Bailing, Dipharma Francis, Grindeks, Suzhou Tianlv, Yun Gang Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Ursodeoxycholic Acid API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Synthetic UDCA
Extraction UDCA

Market segment by Application
Pharmacy
Health Products

Major players covered
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan Bailing
Dipharma Francis
Grindeks
Suzhou Tianlv
Yun Gang Bio

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ursodeoxycholic Acid API product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid API, with price, sales quantity, revenue, and global market share of Ursodeoxycholic Acid API from 2019 to 2024.

Chapter 3, the Ursodeoxycholic Acid API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ursodeoxycholic Acid API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Ursodeoxycholic Acid API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Ursodeoxycholic Acid API.

Chapter 14 and 15, to describe Ursodeoxycholic Acid API sales channel, distributors, customers, research findings and conclusion.